down arrow

The Cigna Group

  • Market Cap: Large Cap
  • Industry: Healthcare Services
  • ISIN: US1255231003
USD
268.42
-1.9 (-0.7%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

266.51272.09

52 Week

239.51350.00
Valuation
Technical
Day's Volume

CASH

1.55 M

Shareholding (Mar 2025)

FII

17.23%

Held by 487 FIIs

DII

42.91%

Held by 68 DIIs

Promoter

0.10%

How big is The Cigna Group?

22-Jun-2025

As of Jun 18, The Cigna Group has a market capitalization of $94.58 billion, with net profit of $5.40 billion and total assets of $151.50 billion.

As of Jun 18, The Cigna Group has a market capitalization of 94,580.40 million, categorizing it as a Large Cap company.<BR><BR>As of Jun 18, the company reported net sales of 0.00 million for the latest four quarters, while the net profit for the same period was 5,399.00 million.<BR><BR>As of Dec 24, the balance sheet shows shareholder's funds of 41,033.00 million and total assets amounting to 151,503.00 million.

Read More

What does The Cigna Group do?

22-Jun-2025

The Cigna Group is a large-cap health services company specializing in healthcare services, with a recent net profit of $1.41 billion and a market capitalization of approximately $94.58 billion. Key metrics include a P/E ratio of 16.00 and a return on equity of 14.33%.

Overview:<BR>The Cigna Group is a health services company that operates in the Healthcare Services industry and falls within the large-cap market category.<BR><BR>Financial Snapshot:<BR>Most recent Net Profit: 1,409 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 94,580.40 Million (Large Cap)<BR><BR>Key Metrics:<BR>P/E: 16.00 <BR>Dividend Yield: 1,079.04% <BR>Debt Equity: -0.13 <BR>Return on Equity: 14.33% <BR>Price to Book: 2.35<BR><BR>Contact Details:<BR>Address: 900 Cottage Grove Rd, BLOOMFIELD CT: 06002-2920 <BR>Tel: ['1 860 2266000', '1 215 7614198'] <BR>Fax: 1 302 6555049 <BR>Website: https://www.cigna.com/

Read More

Who are in the management team of The Cigna Group?

22-Jun-2025

As of March 2022, The Cigna Group's management team includes Mr. Isaiah Harris (Independent Chairman), Mr. David Cordani (CEO), and several independent directors: Ms. Kimberly Ross, Mr. William DeLaney, Mr. Eric Foss, Maj. Gen. Elder Granger, and Ms. Kathleen Mazzarella. They oversee the company's strategic direction and operations.

As of March 2022, the management team of The Cigna Group includes the following individuals:<BR><BR>- Mr. Isaiah Harris, Independent Chairman of the Board<BR>- Mr. David Cordani, Chief Executive Officer and Director<BR>- Ms. Kimberly Ross, Director<BR>- Mr. William DeLaney, Independent Director<BR>- Mr. Eric Foss, Independent Director<BR>- Maj. Gen. Elder Granger, Independent Director<BR>- Ms. Kathleen Mazzarella, Independent Director<BR><BR>This team is responsible for guiding the company's strategic direction and overseeing its operations.

Read More

Is The Cigna Group overvalued or undervalued?

20-Sep-2025

As of July 7, 2025, The Cigna Group is considered overvalued due to a high P/E ratio of 16 compared to peers, an elevated EV to EBITDA ratio of 33.02, and poor performance with a 1-year return of -17.34% versus the S&P 500's 17.14%.

As of 7 July 2025, The Cigna Group's valuation grade has moved from fair to expensive, indicating a shift towards being overvalued. The company is currently assessed as overvalued based on its P/E ratio of 16, which is higher than its peers, such as UnitedHealth Group at 13.13 and Elevance Health at 12.97. Additionally, the EV to EBITDA ratio stands at 33.02, significantly above the industry average, while the PEG ratio of 0.41 suggests that the stock may not be growing at a pace that justifies its current valuation.<BR><BR>In terms of performance, The Cigna Group has underperformed relative to the S&P 500 over several periods, with a 1-year return of -17.34% compared to the S&P 500's 17.14%. This trend reinforces the notion that the stock may be overvalued, as it has not delivered returns commensurate with its price. Overall, the combination of high valuation ratios and poor recent performance suggests that The Cigna Group is currently overvalued.

Read More

Is The Cigna Group technically bullish or bearish?

05-Nov-2025

As of October 31, 2025, The Cigna Group's technical trend is bearish with weak strength indicators, underperforming the S&P 500 significantly over the past year and three years.

As of 31 October 2025, the technical trend for The Cigna Group has changed from mildly bearish to bearish. The current stance is bearish with a weak strength indicated by the weekly MACD and moving averages both showing bearish signals. The monthly MACD is also bearish, while the RSI shows a bullish signal on the monthly timeframe but no signal on the weekly. Bollinger Bands and Dow Theory are both mildly bearish across weekly and monthly periods. <BR><BR>In terms of performance, The Cigna Group has underperformed compared to the S&P 500 across multiple periods, with a 1-year return of -16.38% versus the S&P 500's 19.89%, and a 3-year return of -18.38% compared to 76.66% for the index.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 14.25%

 
2

Positive results in Jun 25

3

With ROE of 14.33%, it has a expensive valuation with a 2.35 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Healthcare Services

stock-summary
Market cap

USD 90,999 Million (Large Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1,150.13%

stock-summary
Debt Equity

-0.02

stock-summary
Return on Equity

14.36%

stock-summary
Price to Book

2.26

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
1,632 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.71%
0%
-11.71%
6 Months
-13.45%
0%
-13.45%
1 Year
-18.69%
0%
-18.69%
2 Years
2.1%
0%
2.1%
3 Years
-17.96%
0%
-17.96%
4 Years
34.3%
0%
34.3%
5 Years
23.33%
0%
23.33%

The Cigna Group for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is The Cigna Group technically bullish or bearish?

As of 31 October 2025, the technical trend for The Cigna Group has changed from mildly bearish to bearish. The current stance is bearish with a weak strength indicated by the weekly MACD and moving averages both showing bearish signals. The monthly MACD is also bearish, while the RSI shows a bullish signal on the monthly timeframe but no signal on the weekly. Bollinger Bands and Dow Theory are both mildly bearish across weekly and monthly periods. In terms of performance, The Cigna Group has underperformed compared to the S&P 500 across multiple periods, with a 1-year return of -16.38% versus the S&P 500's 19.89%, and a 3-year return of -18.38% compared to 76.66% for the index....

Read More

Is The Cigna Group technically bullish or bearish?

As of 31 October 2025, the technical trend for The Cigna Group has changed from mildly bearish to bearish. The current stance is bearish with a weak strength indicated by the weekly MACD and moving averages both showing bearish signals. The Bollinger Bands and Dow Theory also reflect a mildly bearish outlook on the weekly and monthly time frames. The monthly RSI is bullish, but this is countered by the overall bearish sentiment in other indicators. In terms of performance, The Cigna Group has underperformed the S&P 500 across multiple periods, including a -18.28% return over the past year compared to the S&P 500's 19.89%....

Read More

Is The Cigna Group technically bullish or bearish?

As of 31 October 2025, the technical trend for The Cigna Group has changed from mildly bearish to bearish. The current stance is bearish, with key indicators supporting this view including bearish MACD readings on both the weekly and monthly charts, bearish Bollinger Bands, and a bearish daily moving average. The KST shows a mildly bullish signal on the weekly timeframe but is bearish monthly, while the Dow Theory indicates a mildly bearish trend on the monthly timeframe. The stock has underperformed against the S&P 500 across multiple periods, with a 1-year return of -22.36% compared to the S&P 500's 19.89%....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
11.06%
EBIT Growth (5y)
143.16%
EBIT to Interest (avg)
0.67
Debt to EBITDA (avg)
9.18
Net Debt to Equity (avg)
0.10
Sales to Capital Employed (avg)
3.35
Tax Ratio
21.04%
Dividend Payout Ratio
46.19%
Pledged Shares
0
Institutional Holding
89.32%
ROCE (avg)
1.70%
ROE (avg)
14.25%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
2.35
EV to EBIT
NA
EV to EBITDA
33.02
EV to Capital Employed
2.54
EV to Sales
0.35
PEG Ratio
0.41
Dividend Yield
1080.18%
ROCE (Latest)
ROE (Latest)
14.33%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 194 Schemes (39.71%)

Foreign Institutions

Held by 487 Foreign Institutions (17.23%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.18% vs 7.88% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "682.00",
          "val2": "738.00",
          "chgp": "-7.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "337.00",
          "val2": "375.00",
          "chgp": "-10.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-74.00",
          "val2": "-63.00",
          "chgp": "-17.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,632.00",
          "val2": "1,629.00",
          "chgp": "0.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "36.20%",
          "val2": "40.10%",
          "chgp": "-0.39%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -29.67% vs -20.79% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,775.00",
          "val2": "3,028.00",
          "chgp": "-8.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1,435.00",
          "val2": "1,446.00",
          "chgp": "-0.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-275.00",
          "val2": "-498.00",
          "chgp": "44.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,778.00",
          "val2": "5,372.00",
          "chgp": "-29.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.50%",
          "val2": "45.90%",
          "chgp": "-1.74%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
682.00
738.00
-7.59%
Interest
337.00
375.00
-10.13%
Exceptional Items
-74.00
-63.00
-17.46%
Consolidate Net Profit
1,632.00
1,629.00
0.18%
Operating Profit Margin (Excl OI)
36.20%
40.10%
-0.39%
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 0.18% vs 7.88% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
2,775.00
3,028.00
-8.36%
Interest
1,435.00
1,446.00
-0.76%
Exceptional Items
-275.00
-498.00
44.78%
Consolidate Net Profit
3,778.00
5,372.00
-29.67%
Operating Profit Margin (Excl OI)
28.50%
45.90%
-1.74%
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -29.67% vs -20.79% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About The Cigna Group stock-summary
stock-summary
The Cigna Group
Healthcare Services
Cigna Corporation is a health services company that offers medical, dental insurance and related products and services. The Company's segments are Evernorth, U.S. Medical and International Markets. The Company's Evernorth segment is engaged in offering coordinated and point solution health services, including pharmacy services, benefits management, care solutions and data and analytics, which are provided to health plans, employers, government organizations, and health care providers. Its U.S. Medical segment offers U.S. Commercial and U.S. Government health care solutions to employers and individuals. Its International Markets includes supplemental health care coverage in international markets, as well as health care benefits to globally mobile employees of multinational organizations.
Company Coordinates stock-summary
Company Details
900 Cottage Grove Rd , BLOOMFIELD CT : 06002-2920
stock-summary
Tel: 1 860 22660001 215 7614198
stock-summary
https://www.cigna.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."